Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simplified vs Standard Adenosine for SVT
NCT04392362Phase 3Completed
- Sponsor
- University of Pretoria
- Start
- Apr 2018
- Primary completion
- Dec 2020
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of adenosine in supraventricular tachycardia (SVT) (2 arms), sponsored by University of Pretoria. Primary endpoint: Number of Patients With First Dose Successful Termination of the Supraventricular Tachycardia to a Sinus Rhythm of Less Than 140. Started Apr 2018; status: completed.
02
Drugs
adenosine
03
Conditions
supraventricular tachycardia (SVT)
Beyond the preview
Go deeper on NCT04392362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04392362.